Lv41
500 积分 2024-04-11 加入
α-Synuclein pathology as a target in neurodegenerative diseases
6小时前
已完结
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies
1个月前
已完结
Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development
1个月前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
1个月前
已完结
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
1个月前
已完结
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Thalassaemia
2个月前
已完结
Major adverse events associated with lipid reduction in inclisiran: a pharmacovigilance research of the FAERS database
2个月前
已完结
Vutrisiran for ATTR Amyloidosis with Cardiomyopathy
2个月前
已完结
Primary Results From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy
2个月前
已完结
皖公网安备34019202002308
